Skip to content

Observation on the Efficacy of Feire II Formula Combined with Cupping Therapy in the Treatment of Phlegm-Heat Obstructing the Lung Type Pneumonia

Observation on the Efficacy of Feire II Formula Combined with Cupping Therapy in the Treatment of Phlegm-Heat Obstructing the Lung Type Pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000662
Enrollment
Unknown
Registered
2026-03-20
Start date
2023-11-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

community-acquired pneumonia

Interventions

Treatment group:Conventional Western Medical Treatment combined with Feire No. 2 Formula and Cupping Therapy

Sponsors

Fengxian District Traditional Chinese Medicine Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)Meet the diagnostic criteria for community-acquired pneumonia (non-severe) in Western medicine; 2)Meet the diagnostic criteria for the phlegm-heat obstructing the lung syndrome type; 3)Aged 18–75 years, regardless of gender; 4)Curb-65 score of 0–1 points; 5)Agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1)Patients with other respiratory diseases, such as bronchial asthma, bronchiectasis, or other pulmonary conditions;2)Patients with severe cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic system diseases, or psychiatric disorders;3)Patients diagnosed with viral pneumonia;4)Pregnant or lactating women;5)Patients who did not comply with the prescribed medication regimen, making it impossible to evaluate efficacy, or those with incomplete data affecting efficacy assessment;6)Patients currently participating in other clinical trials that may influence the outcome evaluation of this study.

Design outcomes

Primary

MeasureTime frame
Radiographic Resolution of Pneumonia;

Secondary

MeasureTime frame
Relevant inflammatory markers;Score of the Phlegm-Heat Obstructing the Lung Syndrome;

Countries

China

Contacts

Public ContactDonghua Zhou

Fengxian District Traditional Chinese Medicine Hospital, Shanghai

zdhhx@sina.com13818955123

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026